Press Release: Apex Labs Files for US Patent Protecting Psychedelic Drug Delivery System
CNW Group Thu, March 7, 2024 -Patent pending uniquely formulated capsule improves stability and bioavailability for psilocybin and other psychedelics -Supports both APEX-52 take home microdose and APEX-90 in-clinic macrodose psilocybin drug assets VANCOUVER, BC, March 7, 2024 /CNW/ – Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with psilocybin […]